Conflict of interest
Nordisk
DSG: Consultant for Dicerna, Inc., a Novo Nordisk Company, Alnylam, Synlogic, Sumitovant, Orfan, BridgeBio/Cantero; Research funding from Dicerna, Inc., a Novo Nordisk Company, Alnylam, Travere; Owner, Moonstone Nutrition; JCL: Consultant for Alnylam, Dicerna Inc., a Novo Nordisk Company, OxThera, BridgeBio/Cantero, Chinook, BioMarin, Synlogic, Novobiome, Oxidien, Federation Bio, Intellia, Precision BioSciences; Research funding from OxThera, Allena, Siemens, Alnylam, Dicerna, Inc, a Novo Nordisk Company, Synlogic, Novobiome, Arkray; JG: Research funding from Dicerna Inc., a Novo Nordisk Company, Alnylam, UniQure; Consultant for Alnylam Eu 2000 CF; Scientific advisor for Alnylam; serves as chair of OxalEurope; GS has nothing to disclose; KR was an employee of Dicerna Inc., a Novo Nordisk Company at the time of the completion of this study; SY is an employee of Dicerna Inc., a Novo Nordisk Company; and BV is an employee of Novo Nordisk.